Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasm, Residual × Breast × Clear all

Phase

Phase 2 7 Phase EARLY_PHASE1 2 Phase NA 1 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4 Lymphoid 3 Gastrointestinal 2 Tumor-Agnostic 1 Thoracic 1 Breast 1

Conditions

Breast Neoplasms 1000 Triple Negative Breast Neoplasms 70 Neoplasm Metastasis 55 Neoplasms 37 Prostatic Neoplasms 15 Neutropenia 15 Carcinoma, Intraductal, Noninfiltrating 14 Carcinoma, Ductal, Breast 14 Breast Neoplasms, Male 14 Brain Neoplasms 14 Lung Neoplasms 12 Inflammatory Breast Neoplasms 12 Hot Flashes 12 HER2-positive Breast Cancer 12 Breast Diseases 12 Breast Carcinoma In Situ 12 Pain 11 Ovarian Neoplasms 11 Multiple Myeloma 11 Advanced Breast Cancer 11 Recurrence 10 Osteoporosis 10 Vomiting 9 Radiodermatitis 9 Motor Activity 9 Melanoma 9 Lymphoma, Non-Hodgkin 9 Lymphoma, Large B-Cell, Diffuse 9 Carcinoma, Ovarian Epithelial 9 Testicular Neoplasms 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05232916 2026-03-19

FLAMINGO-01

Greenwich LifeSciences, Inc.

Phase 3 Recruiting

Breast Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡